Sun Pharma Advanced Research Company Limited Share Price
Equities
SPARC
INE232I01014
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.09 INR | +3.74% |
|
+21.01% | +28.74% |
| 30/04 | Indian Indices Fall on Thursday as Crude Surge, Global Cues Weigh | MT |
| 30/04 | Sun Pharma Advanced to Sell Rare Paediatric Disease Priority Review Voucher for $195 Million | MT |
| Capitalization | 3.73TCr 39Cr 34Cr 31Cr 29Cr 54Cr 55Cr 364.11Cr 141.94Cr 1.79TCr 148.11Cr 145Cr 6.18TCr | P/E ratio 2024 |
-30.9x | P/E ratio 2025 | -14x |
|---|---|---|---|---|---|
| Enterprise value | 4TCr 42Cr 36Cr 33Cr 31Cr 58Cr 58Cr 390.19Cr 152.1Cr 1.92TCr 158.72Cr 155.38Cr 6.63TCr | EV / Sales 2024 |
157x | EV / Sales 2025 | 70.6x |
| Free-Float |
27.04% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Sun Pharma Advanced Research Company Limited
| 1 day | +3.74% | ||
| 1 week | +21.01% | ||
| Current month | +21.01% | ||
| 1 month | +27.12% | ||
| 3 months | +24.38% | ||
| 6 months | +29.80% | ||
| Current year | +28.74% |
| 1 week | 138.92 |  | 182.59 |
| 1 month | 118.68 | | 182.59 |
| Current year | 108 | | 182.59 |
| 1 year | 108 | | 204.4 |
| 3 years | 108 | | 472.8 |
| 5 years | 108 | | 472.8 |
| 10 years | 81 | | 532 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 24/04/2014 | |
Anup Rathi
DFI | Director of Finance/CFO | - | 06/06/2024 |
| Chief Operating Officer | - | 26/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 09/11/2009 | |
| Director/Board Member | 76 | 19/05/2025 | |
Robert Spiegel
BRD | Director/Board Member | 76 | 01/06/2020 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.74% | +21.01% | +21.40% | -10.48% | 59Cr | |
| -2.72% | -1.54% | +26.22% | +119.18% | 85TCr | |
| -0.53% | -2.58% | +42.18% | +36.36% | 53TCr | |
| -0.57% | -2.44% | +8.61% | +36.69% | 36TCr | |
| -0.94% | -0.97% | +21.32% | +10.98% | 32TCr | |
| +0.23% | -1.24% | +31.68% | +11.93% | 28TCr | |
| +0.05% | -2.19% | +24.42% | +20.97% | 28TCr | |
| -0.82% | -0.70% | +43.44% | -5.91% | 28TCr | |
| -1.76% | +4.42% | -32.32% | -49.34% | 20TCr | |
| +0.79% | +0.57% | +21.93% | +41.38% | 18TCr | |
| Average | -0.03% | +1.43% | +20.89% | +21.18% | 32.76TCr | |
| Weighted average by Cap. | -0.78% | -1.26% | +24.32% | +43.27% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 76Cr 79.99L 67.96L 62.2L 58.7L 1.1Cr 1.1Cr 7.38Cr 2.88Cr 36Cr 3Cr 2.94Cr 125.28Cr | 72Cr 75.99L 64.56L 59.08L 55.77L 1.04Cr 1.05Cr 7.01Cr 2.73Cr 34Cr 2.85Cr 2.79Cr 119.01Cr |
| Net income | -387.21Cr -4.1Cr -3.48Cr -3.19Cr -3.01Cr -5.61Cr -5.66Cr -38Cr -15Cr -185.99Cr -15Cr -15Cr -642.13Cr | -342.51Cr -3.63Cr -3.08Cr -2.82Cr -2.66Cr -4.96Cr -5.01Cr -33Cr -13Cr -164.52Cr -14Cr -13Cr -568Cr |
| Net Debt | -96Cr -1.02Cr -86.34L -79.02L -74.58L -1.39Cr -1.4Cr -9.37Cr -3.65Cr -46Cr -3.81Cr -3.73Cr -159.17Cr | 266.97Cr 2.83Cr 2.4Cr 2.2Cr 2.07Cr 3.87Cr 3.9Cr 26Cr 10Cr 128.24Cr 11Cr 10Cr 442.73Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | 173.09 ₹ | +3.74% | 87,38,847 |
| 07/26/07 | 166.85 ₹ | +6.22% | 72,34,225 |
| 06/26/06 | 157.08 ₹ | +12.20% | 2,16,75,130 |
| 05/26/05 | 140.00 ₹ | +0.21% | 31,59,657 |
| 04/26/04 | 139.70 ₹ | -2.34% | 25,12,572 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Net sales - Rate of surprise
- Stock Market
- Equities
- SPARC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition